JP2021066750A - Antibacterial substance and liquid antibacterial agent, and method for manufacturing liquid antibacterial agent - Google Patents

Antibacterial substance and liquid antibacterial agent, and method for manufacturing liquid antibacterial agent Download PDF

Info

Publication number
JP2021066750A
JP2021066750A JP2021016902A JP2021016902A JP2021066750A JP 2021066750 A JP2021066750 A JP 2021066750A JP 2021016902 A JP2021016902 A JP 2021016902A JP 2021016902 A JP2021016902 A JP 2021016902A JP 2021066750 A JP2021066750 A JP 2021066750A
Authority
JP
Japan
Prior art keywords
antibacterial agent
liquid
silver
antibacterial
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021016902A
Other languages
Japanese (ja)
Other versions
JP7118465B2 (en
JP2021066750A5 (en
Inventor
秀己 柿原
Hidemi Kakihara
秀己 柿原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2021066750A publication Critical patent/JP2021066750A/en
Publication of JP2021066750A5 publication Critical patent/JP2021066750A5/en
Application granted granted Critical
Publication of JP7118465B2 publication Critical patent/JP7118465B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds

Abstract

To provide an antibacterial substance and a liquid antibacterial agent having higher stability than prior antibacterial agents and which can be applied to a variety of antibacterial objects that are liquids.SOLUTION: An antibacterial substance comprises a water-soluble polysaccharide having an average molecular weight of 1,200,000 or greater, to which deposited silver particles having a diameter of 1 nm or greater are caused to adhere in a dispersed state. The antibacterial substance is admixed in a state of dissolved in an aqueous solvent, yielding a liquid antibacterial agent. The silver has a concentration of 80 ppm or greater.SELECTED DRAWING: Figure 1

Description

本発明は、抗菌物質及び液状抗菌剤並びに液状抗菌剤の製造方法に関する。 The present invention relates to an antibacterial substance, a liquid antibacterial agent, and a method for producing a liquid antibacterial agent.

従来、微生物が繁殖して汚染されることを防止するために、種々の抗菌物質が提案されている。 Conventionally, various antibacterial substances have been proposed in order to prevent microorganisms from multiplying and being contaminated.

例えば、化粧料に微生物が繁殖してしまうことを防止するために、パラオキシ安息香酸エステル(所謂、パラベン)が添加されている。 For example, a paraoxybenzoic acid ester (so-called paraben) is added to prevent the growth of microorganisms in cosmetics.

また食品では保存料の類として、安息香酸や安息香酸ナトリウムを添加することにより、微生物の繁殖を抑制して食品の保存性を高めている。 In foods, benzoic acid and sodium benzoate are added as preservatives to suppress the growth of microorganisms and improve the preservability of foods.

しかしながら、これら化粧料や食品など抗菌の対象となる物(以下、単に対象物ともいう。)は、人体の皮膚に接触させたり経口摂取されるものであり、できるだけパラオキシ安息香酸エステルや、安息香酸、安息香酸ナトリウム等を使用することなく、微生物の繁殖を抑制したいという要望がある。 However, these antibacterial substances such as cosmetics and foods (hereinafter, also simply referred to as “objects”) are those that come into contact with the skin of the human body or are orally ingested, and paraoxybenzoic acid esters and benzoic acid as much as possible. , There is a desire to suppress the growth of microorganisms without using sodium benzoate or the like.

そこで本発明者は過去に鋭意研究を行い、微細銀粒子を担持させたポリペプチドを含有する銀溶液と、大根を所定の浸漬液中で発酵し搾汁して得られる大根発酵液とを混合してなる抗菌剤を提案している。 Therefore, the present inventor has conducted diligent research in the past, and mixed a silver solution containing a polypeptide carrying fine silver particles and a radish fermented liquid obtained by fermenting and squeezing radish in a predetermined immersion liquid. We are proposing an antibacterial agent.

この銀溶液と大根発酵液とを混合してなる抗菌剤によれば、非加熱的な抗菌や殺菌が比較的困難なカビや酵母に対して効果的に抗菌や殺菌を行うことができる。 According to the antibacterial agent obtained by mixing the silver solution and the fermented radish solution, it is possible to effectively perform antibacterial and sterilization against mold and yeast which are relatively difficult to sterilize and non-heated antibacterial.

特開2010−059132号公報Japanese Unexamined Patent Publication No. 2010-05913

ところが、上記従来の銀溶液と大根発酵液とを混合してなる抗菌剤は、銀粒子の担体として機能するポリペプチドから銀粒子が脱落しやすいという問題があり、沈殿や凝集が生じる場合があった。 However, the antibacterial agent obtained by mixing the above-mentioned conventional silver solution and fermented radish solution has a problem that silver particles easily fall off from a polypeptide that functions as a carrier of silver particles, and precipitation or aggregation may occur. It was.

本発明は、斯かる事情に鑑みてなされたものであって、上記従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な抗菌物質や液状抗菌剤を提供する。 The present invention has been made in view of such circumstances, and is more stable than an antibacterial agent obtained by mixing the above-mentioned conventional silver solution and radish fermented liquid, and is a variety of liquids. Provide antibacterial substances and liquid antibacterial agents that can be used for antibacterial objects.

また本発明では、上記従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な液状抗菌剤の製造方法や、微生物繁殖抑制方法についても提供する。 Further, in the present invention, a liquid antibacterial agent having higher stability than the antibacterial agent obtained by mixing the above-mentioned conventional silver solution and radish fermented liquid and which can be used for antibacterial objects which are various liquids is produced. Methods and methods for suppressing microbial growth are also provided.

上記従来の課題を解決するために、本発明に係る抗菌物質では、(1)直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなることとした。 In order to solve the above-mentioned conventional problems, the antibacterial substance according to the present invention is composed of (1) a water-soluble polysaccharide having an average molecular weight of 1.2 million or more to which silver precipitated particles having a diameter of 1 nm or more are adhered in a dispersed state. And said.

また、本発明に係る抗菌物質では、(2)前記水溶性多糖類はヒアルロン酸とキサンタンガムとの複合体であることにも特徴を有する。 Further, the antibacterial substance according to the present invention is also characterized in that (2) the water-soluble polysaccharide is a complex of hyaluronic acid and xanthan gum.

また、本発明に係る液状抗菌剤では、(3)上述の抗菌物質を水系溶媒中に溶解させた状態で含有することとした。 Further, in the liquid antibacterial agent according to the present invention, (3) the above-mentioned antibacterial substance is contained in a state of being dissolved in an aqueous solvent.

また、本発明に係る液状抗菌剤では、(4)前記銀の濃度が80ppm以上であることにも特徴を有する。 Further, the liquid antibacterial agent according to the present invention is also characterized in that (4) the concentration of the silver is 80 ppm or more.

また、本発明に係る液状抗菌剤の製造方法では、(5)平均分子量120万以上の水溶性多糖類と、ジアンミン銀イオンと、前記ジアンミン銀イオンの還元能を有する有機酸又は糖とを水系溶媒中で反応させて、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類を含む反応液を得る反応工程と、前記反応液中に含まれるアンモニウム塩や硝酸塩、銀塩を除去して精製し液状抗菌剤とする液状抗菌剤調製工程と、を有することとした。 Further, in the method for producing a liquid antibacterial agent according to the present invention, (5) a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, a diammine silver ion, and an organic acid or sugar having a reducing ability of the diammine silver ion are water-based. A reaction step of reacting in a solvent to obtain a reaction solution containing a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, to which precipitated silver particles having a diameter of 1 nm or more are adhered in a dispersed state, and a reaction solution contained in the reaction solution. It was decided to have a liquid antibacterial agent preparation step of removing ammonium salts, nitrates and silver salts and purifying them into liquid antibacterial agents.

また、本発明に係る液状抗菌剤の製造方法では、(6)前記反応工程はアルカリ条件下で行うことにも特徴を有する。 Further, the method for producing a liquid antibacterial agent according to the present invention is also characterized in that (6) the reaction step is carried out under alkaline conditions.

また、本発明に係る微生物繁殖抑制方法では、(7)対象物に対し、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなる抗菌物質を添加することとした。 Further, in the method for suppressing microbial growth according to the present invention, (7) an antibacterial substance composed of a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, in which silver precipitated particles having a diameter of 1 nm or more are adhered to an object in a dispersed state. Was decided to be added.

本発明に係る抗菌物質によれば、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなることとしたため、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な抗菌物質を提供することができる。 According to the antibacterial substance according to the present invention, it is composed of a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, to which precipitated silver particles having a diameter of 1 nm or more are adhered in a dispersed state. It is possible to provide an antibacterial substance which is highly stable as compared with an antibacterial agent obtained by mixing with and can be used for an antibacterial object which is various liquids.

また、本発明に係る液状抗菌剤によれば、上述の抗菌物質を水系溶媒中に溶解させた状態で含有することとしたため、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な液状抗菌剤を提供することができる。 Further, according to the liquid antibacterial agent according to the present invention, since the above-mentioned antibacterial substance is contained in a state of being dissolved in an aqueous solvent, it can be used as an antibacterial agent obtained by mixing a conventional silver solution and a radish fermented liquid. It is possible to provide a liquid antibacterial agent which is more stable than the other and can be used for antibacterial objects which are various liquids.

また、本発明に係る液状抗菌剤では、前記銀の濃度が80ppm以上であることとすれば、希釈することにより所望する実用的な使用濃度に容易に調整することができる。 Further, in the liquid antibacterial agent according to the present invention, if the silver concentration is 80 ppm or more, it can be easily adjusted to a desired practical use concentration by diluting.

また、本発明に係る液状抗菌剤の製造方法では、平均分子量120万以上の水溶性多糖類と、ジアンミン銀イオンと、前記ジアンミン銀イオンの還元能を有する有機酸又は糖とを水系溶媒中で反応させて、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類を含む反応液を得る反応工程と、前記反応液中に含まれるアンモニウム塩や硝酸塩、銀塩を除去して精製し液状抗菌剤とする液状抗菌剤調製工程と、を有することとしたため、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な液状抗菌剤の製造方法を提供することができる。 Further, in the method for producing a liquid antibacterial agent according to the present invention, a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, diammine silver ion, and an organic acid or sugar having a reducing ability of the diammine silver ion are mixed in an aqueous solvent. A reaction step of reacting to obtain a reaction solution containing a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, to which precipitated silver particles having a diameter of 1 nm or more are adhered in a dispersed state, and an ammonium salt contained in the reaction solution Since it has a liquid antibacterial agent preparation step of removing nitrates and silver salts to purify it into a liquid antibacterial agent, it is more stable than a conventional antibacterial agent obtained by mixing a silver solution and a radish fermented liquid. It is possible to provide a method for producing a liquid antibacterial agent which is high in quality and can be used for antibacterial objects which are various liquids.

また、前記反応工程はアルカリ条件下で行うことにより、担持されず沈殿してしまう銀粒子の量を抑制することができ、しかも、液状抗菌剤の製品安定性、すなわち液状抗菌剤とした後の経時的な沈殿の生成をも抑制することができる。 Further, by performing the reaction step under alkaline conditions, it is possible to suppress the amount of silver particles that are not supported and precipitate, and moreover, the product stability of the liquid antibacterial agent, that is, after the liquid antibacterial agent is prepared. The formation of precipitates over time can also be suppressed.

また、本発明に係る微生物繁殖抑制方法によれば、対象物に対し、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなる抗菌物質を添加することとしたため、種々の微生物の繁殖を抑制することができる。 Further, according to the method for suppressing microbial growth according to the present invention, an antibacterial substance composed of a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, in which precipitated silver particles having a diameter of 1 nm or more are adhered to the object in a dispersed state. Since it is added, it is possible to suppress the growth of various microorganisms.

本実施形態に係る抗菌物質の電子顕微鏡像を示した説明図である。It is explanatory drawing which showed the electron microscope image of the antibacterial substance which concerns on this embodiment.

本発明は、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなる抗菌物質を提供するものである。 The present invention provides an antibacterial substance composed of a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, to which silver precipitated particles having a diameter of 1 nm or more are adhered in a dispersed state.

特に、析出させた銀の粒子の直径を1nm以上とし、より好ましくは1nm以上100nm以下、としているため、カビや酵母に対して極めて優れた抗菌効果や殺菌効果を発揮させることができる。なお、析出させた銀の粒子径が1nmを下回ると二次凝集が生じてしまうため好ましくなく、100nmを上回ると沈殿したり抗菌力が低下するため好ましくない。 In particular, since the diameter of the precipitated silver particles is 1 nm or more, more preferably 1 nm or more and 100 nm or less, it is possible to exert an extremely excellent antibacterial effect and bactericidal effect against mold and yeast. If the particle size of the precipitated silver is less than 1 nm, secondary agglutination occurs, which is not preferable, and if it exceeds 100 nm, precipitation or antibacterial activity is lowered, which is not preferable.

また、銀の粒子を付着させる担体として水溶性多糖類を用いることとしたため、極めて安定性の高い抗菌物質とすることができる。 Further, since a water-soluble polysaccharide is used as a carrier to which silver particles are attached, an extremely stable antibacterial substance can be obtained.

ここで水溶性多糖類は、水系溶媒(例えば、水や、水混和性有機溶媒や、水溶性物質を添加した水)に可溶な多糖類であれば特に限定されるものではない。このような多糖類としては例えば、ヒアルロン酸やコンドロイチン硫酸、フコイダン、サクラン、キサンタンガム等を挙げることができ、特に好適にはヒアルロン酸やサクラン、キサンタンガムを用いることができる。 Here, the water-soluble polysaccharide is not particularly limited as long as it is a polysaccharide soluble in an aqueous solvent (for example, water, a water-miscible organic solvent, or water to which a water-soluble substance is added). Examples of such polysaccharides include hyaluronic acid, chondroitin sulfate, fucoidan, sacran, and xanthan gum, and hyaluronic acid, sacran, and xanthan gum can be particularly preferably used.

また、これらの水溶性多糖類は平均分子量が120万以上であるのが望ましい。平均分子量が120万を下回ると安定性が低下し、銀粒子が水溶性多糖類から脱落したり、凝集し易くなる。平均分子量を120万以上、より好ましくは平均分子量を180万以上とすることにより、水溶性多糖類からの銀の脱落を抑制しつつ、凝集し難い抗菌物質とすることができる。 Further, it is desirable that these water-soluble polysaccharides have an average molecular weight of 1.2 million or more. When the average molecular weight is less than 1.2 million, the stability is lowered, and the silver particles are easily dropped from the water-soluble polysaccharide or aggregated. By setting the average molecular weight to 1.2 million or more, more preferably 1.8 million or more, it is possible to obtain an antibacterial substance that does not easily aggregate while suppressing the loss of silver from the water-soluble polysaccharide.

また、水溶性多糖類は2種以上の水溶性多糖の複合体であっても良い。この場合、特に好ましくはヒアルロン酸とキサンタンガムとの複合体や、ヒアルロン酸とキサンタンガムに加え更なる水溶性多糖を組み合わせた複合体とすることで、極めて安定性の高い抗菌性物質とすることができる。 Further, the water-soluble polysaccharide may be a complex of two or more kinds of water-soluble polysaccharides. In this case, an extremely stable antibacterial substance can be obtained by particularly preferably forming a complex of hyaluronic acid and xanthan gum, or a complex of hyaluronic acid and xanthan gum in addition to a further water-soluble polysaccharide. ..

水溶性多糖類をヒアルロン酸とキサンタンガムとを用いた複合体とした場合、同複合体におけるヒアルロン酸の構成重量割合を「1」とした時のキサンタンガムの構成重量割合は、0.5〜1.5とするのが望ましい。 When the water-soluble polysaccharide is a complex using hyaluronic acid and xanthan gum, the composition weight ratio of xanthan gum in the complex is 0.5 to 1.5 when the composition weight ratio of hyaluronic acid is "1". Is desirable.

キサンタンガムの構成重量割合がヒアルロン酸「1」に対して0.5を下回ると、キサンタンガムによる安定性向上の効果が得られにくくなる。また、キサンタンガムの構成重量割合がヒアルロン酸「1」に対して1.5を上回ると、ヒアルロン酸が元々有する金属粒子の担持機能が過剰量のキサンタンガムにより相殺されてしまい、安定性が低くなるため好ましくない。 When the composition weight ratio of xanthan gum is less than 0.5 with respect to hyaluronic acid "1", it becomes difficult to obtain the effect of improving stability by xanthan gum. Further, if the constituent weight ratio of xanthan gum exceeds 1.5 with respect to hyaluronic acid "1", the carrying function of the metal particles originally possessed by hyaluronic acid is canceled by the excessive amount of xanthan gum, which is not preferable because the stability is lowered. ..

他の水溶性多糖類を加えた場合であっても、水溶性多糖類としてヒアルロン酸とキサンタンガムとを使用して複合体を形成する場合には、ヒアルロン酸の構成重量割合を「1」とした時のキサンタンガムの構成重量割合を0.5〜1.5、すなわちヒアルロン酸とキサンタンガムとの重量割合を大凡1:1±0.5とすることで、銀粒子の脱落・沈殿が効果的に抑制された安定性の高い抗菌性物質とすることができる。 Even when other water-soluble polysaccharides are added, when a complex is formed using hyaluronic acid and xanthan gum as water-soluble polysaccharides, the constituent weight ratio of hyaluronic acid is set to "1". By setting the constituent weight ratio of xanthan gum at that time to 0.5 to 1.5, that is, the weight ratio of hyaluronic acid and xanthan gum to be approximately 1: 1 ± 0.5, the shedding and precipitation of silver particles are effectively suppressed and the stability is high. It can be an antibacterial substance.

また、本実施形態に係る抗菌物質は、水系溶媒中に存在させておくことで、極めて安定した液状抗菌剤として利用することができる。 Further, the antibacterial substance according to the present embodiment can be used as an extremely stable liquid antibacterial agent by being present in an aqueous solvent.

特に、この液状抗菌剤は、銀の濃度を80ppm以上としておくことにより、所定の対象物に適宜添加して希釈させた状態で抗菌効果を発揮する液状抗菌剤として利用することができる。 In particular, this liquid antibacterial agent can be used as a liquid antibacterial agent that exerts an antibacterial effect in a state of being appropriately added to a predetermined object and diluted by setting the silver concentration to 80 ppm or more.

付言すれば、本実施形態に係る抗菌物質は、対象物中において銀の濃度が0.1〜8ppm程度となるように存在させておくことで、優れた抗菌効果や殺菌効果を発揮させることが可能であり、例えば液状抗菌剤の濃度を80ppmとしたならば、10倍〜800倍希釈の範囲で希釈して使用することができる。 In addition, the antibacterial substance according to the present embodiment can exhibit excellent antibacterial effect and bactericidal effect by allowing the silver concentration to be about 0.1 to 8 ppm in the object. Yes, for example, if the concentration of the liquid antibacterial agent is 80 ppm, it can be diluted in the range of 10-fold to 800-fold dilution and used.

また本願では、前述の抗菌物質を含有する液状抗菌剤の製造方法についても提供する。 The present application also provides a method for producing a liquid antibacterial agent containing the above-mentioned antibacterial substance.

具体的には、平均分子量120万以上の水溶性多糖類と、ジアンミン銀イオンと、前記ジアンミン銀イオンの還元能を有する有機酸又は糖とを水系溶媒中で反応させて、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類を含む反応液を得る反応工程と、前記反応液中に含まれるアンモニウム塩や硝酸塩、銀塩を除去して精製し液状抗菌剤とする液状抗菌剤調製工程と、を有することを特徴とする液状抗菌剤の製造方法を提供する。 Specifically, a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, diammine silver ion, and an organic acid or sugar having a reducing ability of the diammine silver ion are reacted in an aqueous solvent to have a diameter of 1 nm or more. A reaction step of obtaining a reaction solution containing a water-soluble polysaccharide having an average molecular weight of 1.2 million or more to which silver precipitated particles are adhered in a dispersed state, and purification by removing ammonium salts, nitrates and silver salts contained in the reaction solution. Provided is a method for producing a liquid antibacterial agent, which comprises a step of preparing a liquid antibacterial agent as a liquid antibacterial agent.

ジアンミン銀イオンは、化学式[Ag(NH3)2]+で表される物質であり、例えば、下記の反応式に従って得ることができる。
2Ag+ + 2OH- → Ag2O + H2O
Ag2O + 4NH3+ H2O → 2[Ag(NH3)2]++ 2OH-
Diammine silver ion is a substance represented by the chemical formula [Ag (NH 3 ) 2 ] + , and can be obtained, for example, according to the following reaction formula.
2Ag + + 2OH - → Ag 2 O + H 2 O
Ag 2 O + 4NH 3 + H 2 O → 2 [Ag (NH 3) 2] + + 2OH -

ジアンミン銀イオンの還元能を有する有機酸は特に限定されるものではないが、同有機酸が酸化された際に色調の変化を来さないものがより好ましい。有機酸としては例えば、アスコルビン酸やクエン酸を用いることができる。 The organic acid having a reducing ability of diammine silver ion is not particularly limited, but one that does not change the color tone when the organic acid is oxidized is more preferable. As the organic acid, for example, ascorbic acid or citric acid can be used.

また、ジアンミン銀イオンの還元能を有する糖についても特に限定されるものではないが、例えばグルコースやキシロース等を用いることができる。 Further, the sugar having a reducing ability of diammine silver ion is not particularly limited, and for example, glucose, xylose or the like can be used.

また各成分は、94.05±5重量部(すなわち、89.05〜99.05重量部)の水系溶媒と、0.95±0.5重量部(すなわち、0.45〜1.45重量部)の平均分子量120万以上の水溶性多糖類と、2.6±2.5重量部(すなわち、0.1〜5.1重量部)のジアンミン銀イオンの還元能を有する有機酸又は糖と、0.035±0.0315重量部(すなわち、0.0035〜0.0665重量部)のジアンミン銀イオンとが混合される割合で用いるのが好ましい。 Each component is composed of 94.05 ± 5 parts by weight (that is, 89.05 to 99.05 parts by weight) of an aqueous solvent and 0.95 ± 0.5 parts by weight (that is, 0.45 to 1.45 parts by weight) of a water-soluble polysaccharide having an average molecular weight of 1.2 million or more. , 2.6 ± 2.5 parts by weight (ie, 0.1 to 5.1 parts by weight) of organic acid or sugar capable of reducing diammine silver ions, and 0.035 ± 0.0315 parts by weight (ie, 0.0035 to 0.0665 parts by weight) of diammine silver ions. It is preferable to use it in a mixed ratio.

また、反応工程を行うにあたっては、水溶性多糖類と、ジアンミン銀イオンと、有機酸との他に、グリセリンやプルラン、グルコースなどの糖などを添加しても良い。 Further, in carrying out the reaction step, sugars such as glycerin, pullulan and glucose may be added in addition to the water-soluble polysaccharide, diammine silver ion and the organic acid.

グリセリンは、反応液中に0.5〜5重量%の濃度で添加しておくことにより、ヒアルロン酸の溶解性を向上できると共に、銀の担持量を増やすことができる。 By adding glycerin to the reaction solution at a concentration of 0.5 to 5% by weight, the solubility of hyaluronic acid can be improved and the amount of silver carried can be increased.

また、グルコースやプルランは、反応液中に0.5〜5重量%、より好ましくは0.5〜3重量%の濃度で添加しておくことにより、銀の安定性を増加させることができる。 Further, the stability of silver can be increased by adding glucose or pullulan to the reaction solution at a concentration of 0.5 to 5% by weight, more preferably 0.5 to 3% by weight.

また、この反応工程は、アルカリ条件下や過アルカリ条件下で行うようにしても良い。例えば、後述する〔2.液状抗菌剤の調製〕の調製例2にて述べる配合割合の反応液のpHに対して±0.5程度のpHの範囲内のアルカリ性条件下とすることにより、担持されず沈殿してしまう銀粒子の量を抑制することができ、しかも、液状抗菌剤の製品安定性、すなわち液状抗菌剤とした後の経時的な沈殿の生成をも抑制することができる。また、敢えて一例を挙げるならば、反応時のpHは例えば9〜12程度、より好ましくはpH10〜12程度とすることができる。 Further, this reaction step may be carried out under alkaline conditions or per-alkaline conditions. For example, it will be described later [2. Preparation of liquid antibacterial agent] The silver particles that are not supported and precipitate under alkaline conditions within the pH range of about ± 0.5 with respect to the pH of the reaction solution in the blending ratio described in Preparation Example 2. The amount can be suppressed, and the product stability of the liquid antibacterial agent, that is, the formation of precipitation over time after the liquid antibacterial agent is used can also be suppressed. To give an example, the pH at the time of reaction can be, for example, about 9 to 12, more preferably about 10 to 12.

抗菌剤調製工程は、反応工程により得られた直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類を含む反応液から、アンモニウム塩や硝酸塩、銀塩等の塩類や未反応のジアンミン銀イオン、有機酸等を除去して液状抗菌剤とするための工程である。 In the antibacterial agent preparation step, ammonium salts, nitrates, and silver are prepared from a reaction solution containing water-soluble polysaccharides having an average molecular weight of 1.2 million or more, which is obtained by adhering precipitated silver particles having a diameter of 1 nm or more in a dispersed state. This is a step for removing salts such as salts, unreacted quaternary silver ions, organic acids and the like to obtain a liquid antibacterial agent.

本工程は、例えば分子量の違い等を利用して除去するなど公知の方法を採用することができ、より具体的には、透析を採用するのも一案である。 In this step, a known method such as removal by utilizing a difference in molecular weight can be adopted, and more specifically, dialysis may be adopted.

また、本抗菌剤調製工程では、精製工程にて得られた溶液に対し、適宜水系溶媒等を添加して希釈することにより本実施形態に係る抗菌物質の含有濃度を調整して本実施形態に係る液状抗菌剤を調製するようにしても良い。 Further, in the present antibacterial agent preparation step, the content concentration of the antibacterial substance according to the present embodiment is adjusted by appropriately adding an aqueous solvent or the like to the solution obtained in the purification step to dilute the solution to the present embodiment. Such a liquid antibacterial agent may be prepared.

このように、本実施形態に係る液状抗菌剤の製造方法によれば、上述の反応工程と、抗菌剤調製工程とを経ることにより、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な液状抗菌剤を製造することができる。 As described above, according to the method for producing a liquid antibacterial agent according to the present embodiment, the antibacterial agent obtained by mixing the conventional silver solution and the radish fermented liquid through the above-mentioned reaction step and the antibacterial agent preparation step. It is possible to produce a liquid antibacterial agent which is more stable than the agent and can be used for antibacterial objects which are various liquids.

以下、本実施形態に係る抗菌物質、液状抗菌剤、液状抗菌剤の製造方法、微生物繁殖抑制方法について、実験結果等を参照しつつ更に具体的に説明する。なお、以下の説明では、平均分子量120万以上の水溶性多糖類として平均分子量が120万のヒアルロン酸Naや分子量180万〜220万、好ましくは200万程度のキサンタンガムを用い、ジアンミン銀イオンの還元能を有する有機酸又は糖としてクエン酸やグルコースを用いた例について説明するが、必ずしもこれらの組み合わせに限定されるものではない。ただし、出願人がこれらの組み合わせに限定することも妨げない。 Hereinafter, the antibacterial substance, the liquid antibacterial agent, the method for producing the liquid antibacterial agent, and the method for suppressing the growth of microorganisms according to the present embodiment will be described more specifically with reference to the experimental results and the like. In the following description, sodium hyaluronate having an average molecular weight of 1.2 million and xanthan gum having a molecular weight of 1.8 to 2.2 million, preferably about 2 million are used as water-soluble polysaccharides having an average molecular weight of 1.2 million or more to reduce diammine silver ions. An example in which citric acid or glucose is used as a capable organic acid or sugar will be described, but the present invention is not necessarily limited to a combination thereof. However, it does not prevent the applicant from limiting to these combinations.

〔1.ジアンミン銀イオン溶液の調製〕
まず、ジアンミン銀イオン溶液の調製を次の通り行った。すなわち、0.1mol/Lの硝酸銀水溶液10mlに対し、1.0mol/Lの水酸化ナトリウム水溶液1mlを添加して十分に攪拌した。次いで、濁った混合液に対し、2.5%アンモニア水を混合液が透明になるまで(約4ml)添加して、銀濃度が約7000ppmのジアンミン銀イオン溶液を調製した。(ジアンミン銀イオン溶液A)
[1. Preparation of diammine silver ion solution]
First, the diammine silver ion solution was prepared as follows. That is, 1 ml of 1.0 mol / L sodium hydroxide aqueous solution was added to 10 ml of 0.1 mol / L silver nitrate aqueous solution, and the mixture was sufficiently stirred. Then, 2.5% aqueous ammonia was added to the turbid mixture until the mixture became transparent (about 4 ml) to prepare a diammine silver ion solution having a silver concentration of about 7,000 ppm. (Dianmin silver ion solution A)

また別途、500ml容量のビーカーに334.69g量り取った0.1mol/L硝酸銀水溶液に対し、33.47gの1.0mol/L水酸化ナトリウム水溶液を添加して十分に攪拌し、濁った混合液に対し、167.34gの2.5%アンモニア水を混合液が透明になるまで添加して、銀濃度が約7000ppmのジアンミン銀イオン溶液を調製した。(ジアンミン銀イオン溶液B) Separately, add 33.47 g of 1.0 mol / L sodium hydroxide aqueous solution to 334.69 g of 0.1 mol / L silver nitrate aqueous solution weighed in a 500 ml beaker and stir well. 2.5% aqueous ammonia of g was added until the mixture became clear to prepare a diammine silver ion solution having a silver concentration of about 7000 ppm. (Dianmin silver ion solution B)

〔2.液状抗菌剤の調製〕
ビーカーに平均分子量120万のヒアルロン酸ナトリウムを0.95重量部量り取り、94.05重量部の水を加えて溶解させ、このヒアルロン酸ナトリウム水溶液に対し、0.1重量部のクエン酸を添加し、30℃にて十分に攪拌を行った。次に、5重量部のジアンミン銀イオン溶液Aを更に添加し、30℃にて22時間攪拌を行うことにより反応工程を行うことで反応液を得た。なお、以下においてこの反応液をHA-Ag(cit)と言う。
[2. Preparation of liquid antibacterial agent]
Weigh 0.95 parts by weight of sodium hyaluronate having an average molecular weight of 1.2 million in a beaker, add 94.05 parts by weight of water to dissolve it, add 0.1 parts by weight of citric acid to this aqueous sodium hyaluronate solution, and at 30 ° C. Sufficient stirring was performed. Next, 5 parts by weight of diammine silver ion solution A was further added, and the reaction step was carried out by stirring at 30 ° C. for 22 hours to obtain a reaction solution. In the following, this reaction solution will be referred to as HA-Ag (cit).

また、3.5kgの水を収容した20kg容量のステンレス製タンク内へ36gのヒアルロン酸ナトリウムと36gのキサンタンガムとを添加し、プロペラ攪拌機で300rpmの回転速度で攪拌しながら更に10kgの水を添加して40℃にて溶解させた。次いで、このヒアルロン酸ナトリウムとキサンタンガムとの混合水溶液(以下、HAXA水溶液という。)に対し攪拌を継続しながらジアンミン銀イオン溶液Bを反応液中で銀の濃度が終濃度250ppmとなる量で添加し、その5〜30分後に15gの2.5%アンモニア水とを添加してアルカリ(過アルカリ)の状態とし、その5〜30分後に、予め892.5gの水に225gのグルコースを溶解させたグルコース溶液を添加して5〜15分攪拌し、攪拌を停止して1.5〜3時間以上静置反応させることで反応液を得た。この時の反応液のpHは10.5であった。なお、以下においてこの反応液をHAXA-Ag(gul/am)と称する。 In addition, 36 g of sodium hyaluronate and 36 g of xanthan gum were added to a 20 kg capacity stainless steel tank containing 3.5 kg of water, and another 10 kg of water was added while stirring at a rotation speed of 300 rpm with a propeller stirrer. It was dissolved at 40 ° C. Next, diammine silver ion solution B was added to the mixed aqueous solution of sodium hyaluronate and xanthan gum (hereinafter referred to as HAXA aqueous solution) in an amount such that the final concentration of silver was 250 ppm in the reaction solution while continuing stirring. , 5 to 30 minutes later, add 15 g of 2.5% aqueous ammonia to make it alkaline (hyaluronic acid), and 5 to 30 minutes later, add a glucose solution in which 225 g of glucose is dissolved in 892.5 g of water in advance. The mixture was added and stirred for 5 to 15 minutes, the stirring was stopped, and the reaction was allowed to stand for 1.5 to 3 hours or more to obtain a reaction solution. The pH of the reaction solution at this time was 10.5. In the following, this reaction solution will be referred to as HAXA-Ag (gul / am).

また、HAXA-Ag(gul/am)と同様の調製手順であるが、2.5%アンモニア水を添加することなく調製を行った反応液も得た。この時の反応液のpHは9.5であった。以下においてこの反応液をHAXA-Ag(gul)という。 In addition, a reaction solution prepared by the same preparation procedure as HAXA-Ag (gul / am) without adding 2.5% aqueous ammonia was also obtained. The pH of the reaction solution at this time was 9.5. Hereinafter, this reaction solution is referred to as HAXA-Ag (gul).

次に、これら反応工程を経て得られた各反応液をそれぞれ所定量ずつ分取して透析チューブに収容し、この透析チューブを混合液量の約10倍の容量を有する容器に入れて流水下で一昼夜透析し、その後透析チューブから取り出して液状抗菌剤を得た。得られた液状抗菌剤HA-Ag(cit)中の銀濃度は140±20ppmであった。また、液状抗菌剤HAXA-Ag(gul/am)中の銀濃度は200±20ppm、液状抗菌剤HAXA-Ag(gul)中の銀濃度は160±20ppmであった。 Next, each reaction solution obtained through these reaction steps is dispensed by a predetermined amount and contained in a dialysis tube, and the dialysis tube is placed in a container having a capacity of about 10 times the volume of the mixed solution under running water. The dialysis was performed overnight, and then the dialysis tube was taken out to obtain a liquid antibacterial agent. The silver concentration in the obtained liquid antibacterial agent HA-Ag (cit) was 140 ± 20 ppm. The silver concentration in the liquid antibacterial agent HAXA-Ag (gul / am) was 200 ± 20 ppm, and the silver concentration in the liquid antibacterial agent HAXA-Ag (gul) was 160 ± 20 ppm.

〔3.精製度合い確認試験〕
次に、得られた各液状抗菌剤中に、アンモニウム塩や硝酸塩、銀塩が含まれているか否かについて確認を行った。
[3. Purification degree confirmation test]
Next, it was confirmed whether or not each of the obtained liquid antibacterial agents contained an ammonium salt, a nitrate, or a silver salt.

まず、得られた各液状抗菌剤に対し、過剰量の水酸化ナトリウム水溶液を添加して加温し、臭気の有無と発生するガスのpHとの確認とを行うことで、アンモニウム塩の存在について検証した。液状抗菌剤にアンモニウム塩が含まれているならば、アンモニア臭が感じられ、発生するガスをpH試験紙に接触させることでアルカリ性を呈する。 First, each of the obtained liquid antibacterial agents was heated by adding an excessive amount of an aqueous sodium hydroxide solution, and the presence or absence of an odor and the pH of the generated gas were confirmed to determine the presence of the ammonium salt. Verified. If the liquid antibacterial agent contains an ammonium salt, an ammonia odor is felt, and the generated gas is brought into contact with pH test paper to become alkaline.

その結果、いずれの液状抗菌剤からもアンモニア臭は感じられず、また、pH試験紙の色調にも変化は見られなかった。この結果から、各液状抗菌剤には、アンモニウム塩が含まれていない(検出限界以下である)ことが確認された。 As a result, no ammonia odor was felt from any of the liquid antibacterial agents, and no change was observed in the color tone of the pH test paper. From this result, it was confirmed that each liquid antibacterial agent did not contain an ammonium salt (below the detection limit).

次に、得られた各液状抗菌剤に対し、ジフェニルアミン試液を添加して反応させ、反応液の色調変化について確認を行った。液状抗菌剤に硝酸塩が含まれているならば、反応液は青色に変化する。 Next, a diphenylamine test solution was added to each of the obtained liquid antibacterial agents and reacted, and the change in color tone of the reaction solution was confirmed. If the liquid antibacterial agent contains nitrates, the reaction will turn blue.

その結果、いずれの液状抗菌剤においても反応液の色調は変化せず、各液状抗菌剤には硝酸塩が含まれていない(検出限界以下である)ことが確認された。 As a result, it was confirmed that the color tone of the reaction solution did not change with any of the liquid antibacterial agents, and that each liquid antibacterial agent did not contain nitrate (below the detection limit).

次に、得られた各液状抗菌剤に対し、希塩酸を添加して反応させ、沈殿の有無について確認を行った。液状抗菌剤に銀塩が含まれているならば、白色沈殿が生じる。 Next, dilute hydrochloric acid was added to each of the obtained liquid antibacterial agents and reacted, and the presence or absence of precipitation was confirmed. If the liquid antibacterial agent contains silver salts, a white precipitate will occur.

その結果、いずれの液状抗菌剤においても白色沈殿が生じることはなく、各液状抗菌剤には銀塩が含まれていない(検出限界以下である)ことが確認された。 As a result, it was confirmed that no white precipitate was formed in any of the liquid antibacterial agents, and that each liquid antibacterial agent did not contain a silver salt (below the detection limit).

このように、本実施形態に係る液状抗菌剤には、アンモニウム塩、硝酸塩、銀塩が含まれていないことが確認された。 As described above, it was confirmed that the liquid antibacterial agent according to the present embodiment does not contain ammonium salt, nitrate, and silver salt.

〔4.電子顕微鏡による確認試験〕
次に、電子顕微鏡にて液状抗菌剤中に含まれる抗菌物質について観察を行った。液状抗菌剤HA-Ag(cit)の電子顕微鏡像を図1に示す。
[4. Confirmation test with an electron microscope]
Next, the antibacterial substance contained in the liquid antibacterial agent was observed with an electron microscope. An electron microscope image of the liquid antibacterial agent HA-Ag (cit) is shown in FIG.

図1からも分かるように、液状抗菌剤HA-Ag(cit)中の抗菌物質は、水溶性多糖類のマトリクス中に直径1nm以上、大凡1nm〜100nm程度に析出した銀粒子が分散状態で付着している(担持されている)のが観察された。また、図示は割愛するが、液状抗菌剤HAXA-Ag(gul/am)、液状抗菌剤HAXA-Ag(gul)のいずれにおいても、水溶性多糖類のマトリクス中に直径1nm以上、大凡1nm〜100nm程度に析出した銀粒子が分散状態で付着している(担持されている)のが観察された。 As can be seen from FIG. 1, the antibacterial substance in the liquid antibacterial agent HA-Ag (cit) has silver particles precipitated in a matrix of water-soluble polysaccharides having a diameter of 1 nm or more and approximately 1 nm to 100 nm in a dispersed state. It was observed that it was (supported). Although not shown, both the liquid antibacterial agent HAXA-Ag (gul / am) and the liquid antibacterial agent HAXA-Ag (gul) have a diameter of 1 nm or more and approximately 1 nm to 100 nm in the matrix of water-soluble polysaccharides. It was observed that the silver particles precipitated to some extent were attached (supported) in a dispersed state.

〔5.抗菌性確認試験〕
次に、本実施形態に係る液状抗菌剤について、抗菌性の確認試験を行った。具体的には、本実施形態に係る液状抗菌剤HA-Ag(cit)、液状抗菌剤HAXA-Ag(gul/am)、液状抗菌剤HAXA-Ag(gul)のそれぞれを2%(w/w)で添加した化粧水を20mlずつ複数の容器に分注し、大腸菌液(Esherichia coli ; 3.1×108cfu/ml)、黄色ブドウ球菌液(Staphylococcus aureus ; 2.1×108cfu/ml)、緑膿菌液(Pseudomonas aeruginosa ; 2.5×108cfu/ml)、枯草菌液(Bacillus subtilis ; 4.0×107cfu/ml)、カンジダ液(Candida albicans ; 8.6×108cfu/ml)、黒カビ液(Aspergillus niger ; 2.6×108cfu/ml)をそれぞれ0.2ml添加して、4週間に亘り経過を観察した。液状抗菌剤HA-Ag(cit)にて得られた結果を表1に示す。

Figure 2021066750
[5. Antibacterial confirmation test]
Next, a confirmation test of antibacterial properties was conducted on the liquid antibacterial agent according to the present embodiment. Specifically, 2% (w / w) of each of the liquid antibacterial agent HA-Ag (cit), the liquid antibacterial agent HAXA-Ag (gul / am), and the liquid antibacterial agent HAXA-Ag (gul) according to the present embodiment. ), Dispense 20 ml each into multiple containers, Esherichia coli (3.1 × 10 8 cfu / ml), Staphylococcus aureus (2.1 × 10 8 cfu / ml), green Pseudomonas aeruginosa (2.5 × 10 8 cfu / ml), Bacillus subtilis (4.0 × 10 7 cfu / ml), Candida albicans (8.6 × 10 8 cfu / ml), Black mold (Bacillus subtilis; 4.0 × 10 7 cfu / ml) Aspergillus niger; 2.6 × 10 8 cfu / ml) was added in an amount of 0.2 ml each, and the course was observed for 4 weeks. The results obtained with the liquid antibacterial agent HA-Ag (cit) are shown in Table 1.
Figure 2021066750

表1中において括弧は、本実施形態に係る液状抗菌剤を添加しない場合の経過を示している。表1からも分かるように、本実施形態に係る液状抗菌剤を添加しない場合には、6種の試験菌のいずれにおいても微生物の繁殖が確認された。 In Table 1, parentheses indicate the process when the liquid antibacterial agent according to the present embodiment is not added. As can be seen from Table 1, when the liquid antibacterial agent according to the present embodiment was not added, the growth of microorganisms was confirmed in all of the 6 types of test bacteria.

一方、本実施形態に係る液状抗菌剤を添加した場合には、6種の試験菌のいずれにおいても、微生物の増殖抑制効果が観察された。特に、大腸菌や緑膿菌、カンジダに対しては、接種1日経過後において生菌が観察されず、極めて強力な増殖抑制効果が観察された。また、黄色ブドウ球菌に関しても、3日後には生菌が観察されなかった。 On the other hand, when the liquid antibacterial agent according to the present embodiment was added, the effect of suppressing the growth of microorganisms was observed in all of the six test bacteria. In particular, for Escherichia coli, Pseudomonas aeruginosa, and Candida, no viable bacteria were observed one day after inoculation, and an extremely strong growth inhibitory effect was observed. As for Staphylococcus aureus, no viable bacteria were observed after 3 days.

枯草菌に対しては、4週間経過後も完全に死滅させるには至らなかったものの、芽胞を形成する微生物に対してその菌数を107から102オーダーまで低減させており、芽胞形成菌に対しても有効であることが示唆された。 For B. subtilis, but did not reach to also completely killed after 4 weeks, and the number of bacteria was reduced from 10 7 to 10 2 orders to microorganisms that form spores, spore-forming bacteria It was suggested that it is also effective against.

また、黒カビについても同様、4週間経過後も完全に死滅させるには至らなかったものの、その菌数を108から101オーダーまで低減させており、カビに対しても有効であることが示された。 Further, same applies to the black mold, but did not reach to 4 weeks elapsed after completely killed, the number of bacteria is reduced from 10 8 to 10 1 order, it indicates that it is also effective against fungi Was done.

また、具体的なデータは割愛するが、液状抗菌剤HAXA-Ag(gul/am)、液状抗菌剤HAXA-Ag(gul)のいずれにおいても、液状抗菌剤HA-Ag(cit)と略同様の抗菌傾向が観察された。 Although specific data are omitted, the liquid antibacterial agent HAXA-Ag (gul / am) and the liquid antibacterial agent HAXA-Ag (gul) are almost the same as the liquid antibacterial agent HA-Ag (cit). An antibacterial tendency was observed.

これらのことから、本実施形態に係る抗菌物質や液状抗菌剤は、極めて広範な菌種に対して有効であることが示された。 From these facts, it was shown that the antibacterial substance and the liquid antibacterial agent according to the present embodiment are effective against an extremely wide range of bacterial species.

〔6.安定性試験(1)〕
次に、種々の界面活性剤の存在下における本実施形態に係る抗菌物質や液状抗菌剤の安定性について検討を行った。
[6. Stability test (1)]
Next, the stability of the antibacterial substance and the liquid antibacterial agent according to the present embodiment in the presence of various surfactants was examined.

具体的には、アニオン系界面活性剤であるココイルグルタミン酸カリウムの12%水溶液と、カチオン系界面活性剤である塩化セチルトリメチルアンモニウムの24%水溶液と、両性界面活性剤であるラウラミドプロピルベタインの30%水溶液と、ノニオン系界面活性剤であるポリオキシエチルオクチルアミンの1%水溶液とに対し、本実施形態に係る液状抗菌剤を添加して凝集や沈殿が起こるか否かについて確認を行った。なお本試験では、カチオン化キトサンであるキトサンステアラミドヒドロキシプロピルトリモニウムクロリドの1.5%水溶液に対しても試験を行った。 Specifically, a 12% aqueous solution of potassium cocoyl glutamate, which is an anionic surfactant, a 24% aqueous solution of cetyltrimethylammonium chloride, which is a cationic surfactant, and 30 of lauramidopropyl betaine, which is an amphoteric surfactant. It was confirmed whether or not aggregation or precipitation occurs by adding the liquid antibacterial agent according to the present embodiment to the% aqueous solution and the 1% aqueous solution of polyoxyethyl octylamine which is a nonionic surfactant. In this test, a 1.5% aqueous solution of chitosan stearamide hydroxypropyltrimonium chloride, which is a cationized chitosan, was also tested.

また、比較対象として、先述した従来の抗菌剤である銀溶液と大根発酵液とを混合してなる抗菌剤を同様に添加して試験を行った。 In addition, as a comparison target, a test was conducted by similarly adding an antibacterial agent obtained by mixing a silver solution, which is a conventional antibacterial agent, and a fermented radish solution.

その結果、本実施形態に係る液状抗菌剤(HA-Ag(cit)、HAXA-Ag(gul/am)、HAXA-Ag(gul))は、いずれもカチオン系界面活性剤の水溶液に対しては凝集及び沈殿が観察されたものの、それ以外のアニオン系界面活性剤、両性界面活性剤、ノニオン系界面活性剤、カチオン化キトサンの各水溶液においては、凝集や沈殿は観察されなかった。 As a result, the liquid antibacterial agents (HA-Ag (cit), HAXA-Ag (gul / am), HAXA-Ag (gul)) according to the present embodiment are all resistant to the aqueous solution of the cationic surfactant. Although aggregation and precipitation were observed, no aggregation or precipitation was observed in each of the other aqueous solutions of anionic surfactant, amphoteric surfactant, nonionic surfactant, and cationized chitosan.

一方、従来の銀溶液と大根発酵液とを混合してなる抗菌剤は、カチオン系界面活性剤である塩化セチルトリメチルアンモニウムの24%水溶液と、カチオン化キトサンであるキトサンステアラミドヒドロキシプロピルトリモニウムクロリドの1.5%水溶液において凝集や沈殿が観察された。 On the other hand, the antibacterial agents obtained by mixing a conventional silver solution and a radish fermented solution are a 24% aqueous solution of cetyltrimethylammonium chloride, which is a cationic surfactant, and chitosan stealamide hydroxypropyltrimonium chloride, which is a cationized chitosan. Aggregation and precipitation were observed in the 1.5% aqueous solution of.

これらの結果から、本実施形態に係る抗菌物質や液状抗菌剤は、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能であることが示された。 From these results, the antibacterial substance and the liquid antibacterial agent according to the present embodiment are more stable than the antibacterial agent obtained by mixing a conventional silver solution and a radish fermented liquid, and are various liquids. It has been shown that it can be used for antibacterial objects.

〔7.安定性試験(2)〕
HLB値の異なる各種ショ糖脂肪酸エステルの存在化における、本実施形態に係る抗菌物質や液状抗菌剤の安定性について検討を行った。
[7. Stability test (2)]
The stability of antibacterial substances and liquid antibacterial agents according to this embodiment was investigated in the presence of various sucrose fatty acid esters having different HLB values.

具体的には、所定量の水に対し1%(w/w)に相当するショ糖脂肪酸エステルを添加し、溶解可能なものについては十分に溶解させた後、本実施形態に係る液状抗菌剤(HA-Ag(cit)、HAXA-Ag(gul/am)、HAXA-Ag(gul))を2%(w/w)添加し、十分に振盪させて3日間静置して沈殿や凝集の有無について確認した。ショ糖脂肪酸エステルは、HLB値が19、15、13、11、9.5、8、6、2、1のものを用いた。 Specifically, 1% (w / w) of sucrose fatty acid ester is added to a predetermined amount of water, and if it is soluble, it is sufficiently dissolved, and then the liquid antibacterial agent according to the present embodiment is sufficiently dissolved. Add 2% (w / w) of (HA-Ag (cit), HAXA-Ag (gul / am), HAXA-Ag (gul)), shake well and leave for 3 days to allow precipitation and aggregation. I confirmed the existence. As the sucrose fatty acid ester, those having HLB values of 19, 15, 13, 11, 9.5, 8, 6, 2, 1 were used.

また比較対象として、従来の抗菌剤である銀溶液と大根発酵液とを混合してなる抗菌剤を同様に添加して試験を行った。 For comparison, a test was conducted by similarly adding an antibacterial agent obtained by mixing a silver solution, which is a conventional antibacterial agent, and a fermented radish solution.

その結果、本実施形態に係る液状抗菌剤は、いずれのHLB値のショ糖脂肪酸エステル存在下においても沈殿や凝集は観察されなかった。 As a result, no precipitation or aggregation was observed in the liquid antibacterial agent according to the present embodiment in the presence of any HLB value of sucrose fatty acid ester.

一方、従来の銀溶液と大根発酵液とを混合してなる抗菌剤は、HLB値が19、15、13、11のサンプルにおいて凝集や沈殿が観察された。 On the other hand, in the antibacterial agent obtained by mixing the conventional silver solution and the fermented radish solution, aggregation and precipitation were observed in the samples having HLB values of 19, 15, 13 and 11.

これらの結果から、本実施形態に係る抗菌物質や液状抗菌剤は、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して、安定性が高く、しかも、種々の液体である抗菌対象物に使用可能であることが示された。 From these results, the antibacterial substance and the liquid antibacterial agent according to the present embodiment are more stable than the antibacterial agent obtained by mixing a conventional silver solution and a radish fermented liquid, and can be used in various liquids. It has been shown to be usable for certain antibacterial objects.

〔8.安定性試験(3)〕
次に、本実施形態に係る液状抗菌剤をボディーソープに添加した場合の沈殿や凝集の有無について検討を行った。
[8. Stability test (3)]
Next, the presence or absence of precipitation and aggregation when the liquid antibacterial agent according to the present embodiment was added to the body soap was examined.

具体的には、約200gのボディーソープに対し、本実施形態に係る液状抗菌剤(HA-Ag(cit)、HAXA-Ag(gul/am)、HAXA-Ag(gul))を0.5%(w/w)添加して静置し、沈殿や凝集が生じるか否かについて観察を行った。 Specifically, 0.5% (w) of the liquid antibacterial agents (HA-Ag (cit), HAXA-Ag (gul / am), HAXA-Ag (gul)) according to this embodiment is added to about 200 g of body soap. / w) It was added and allowed to stand, and it was observed whether precipitation or aggregation occurred.

その結果、沈殿や凝集は観察されず、本実施形態に係る抗菌物質や液状抗菌剤は、極めて安定性が高いことが示された。 As a result, no precipitation or aggregation was observed, and it was shown that the antibacterial substance and the liquid antibacterial agent according to the present embodiment have extremely high stability.

〔9.安定性試験(4)〕
次に、本実施形態に係る液状抗菌剤の安定性の経時変化について検討を行った。
[9. Stability test (4)]
Next, the change over time in the stability of the liquid antibacterial agent according to the present embodiment was examined.

具体的には、50ml容量で尖鋭形状の透明プラスチック容器内に、液状抗菌剤HA-Ag(cit)、液状抗菌剤HAXA-Ag(gul/am)、液状抗菌剤HAXA-Ag(gul)をそれぞれ45mlずつ分注し、65℃に設定したインキュベータ内に収容して8週間(約2ヶ月間)加速試験に供した。 Specifically, the liquid antibacterial agent HA-Ag (cit), the liquid antibacterial agent HAXA-Ag (gul / am), and the liquid antibacterial agent HAXA-Ag (gul) are placed in a transparent plastic container having a capacity of 50 ml and a sharp shape. 45 ml each was dispensed, placed in an incubator set at 65 ° C., and subjected to an accelerated test for 8 weeks (about 2 months).

また比較対象として、従来の抗菌剤である銀溶液と大根発酵液とを混合してなる抗菌剤を同様に添加して試験を行った。その結果を表2に示す。

Figure 2021066750
For comparison, a test was conducted by similarly adding an antibacterial agent obtained by mixing a silver solution, which is a conventional antibacterial agent, and a fermented radish solution. The results are shown in Table 2.
Figure 2021066750

表2からも分かるように、本実施形態に係る液状抗菌剤はいずれも、従来の銀溶液と大根発酵液とを混合してなる抗菌剤と比較して、良好な安定性が確認された。 As can be seen from Table 2, all of the liquid antibacterial agents according to the present embodiment were confirmed to have good stability as compared with the antibacterial agents obtained by mixing a conventional silver solution and a fermented radish solution.

また、液状抗菌剤HAXA-Ag(gul/am)、液状抗菌剤HAXA-Ag(gul)は、HA-Ag(cit)に比して、より高い安定性を備えていることが確認された。特に、液状抗菌剤HAXA-Ag(gul/am)は6週間経過後においても銀粒子の沈殿が確認されず、極めて高い製品安定性を備えていることが示唆された。 It was also confirmed that the liquid antibacterial agent HAXA-Ag (gul / am) and the liquid antibacterial agent HAXA-Ag (gul) have higher stability than HA-Ag (cit). In particular, the liquid antibacterial agent HAXA-Ag (gul / am) did not show precipitation of silver particles even after 6 weeks, suggesting that it has extremely high product stability.

上述してきたように、本実施形態に係る抗菌物質によれば、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量180万以上の水溶性多糖類よりなることとしたため、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な抗菌物質を提供することができる。 As described above, the antibacterial substance according to the present embodiment is composed of a water-soluble polysaccharide having an average molecular weight of 1.8 million or more, to which precipitated silver particles having a diameter of 1 nm or more are adhered in a dispersed state. It is possible to provide an antibacterial substance having high stability as compared with an antibacterial agent obtained by mixing a silver solution of radish and a fermented radish solution, and which can be used for antibacterial objects which are various liquids.

また、本実施形態に係る液状抗菌剤の製造方法によれば、平均分子量180万以上の水溶性多糖類と、ジアンミン銀イオンと、前記ジアンミン銀イオンの還元能を有する有機酸又は糖とを水系溶媒中で反応させて、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量180万以上の水溶性多糖類を含む反応液を得る反応工程と、前記反応液中に含まれるアンモニウム塩や硝酸塩、銀塩を除去して精製し液状抗菌剤とする液状抗菌剤調製工程と、を有することとしたため、従来の銀溶液と大根発酵液とを混合してなる抗菌剤に比して安定性が高く、しかも、種々の液体である抗菌対象物に使用可能な液状抗菌剤の製造方法を提供することができる。 Further, according to the method for producing a liquid antibacterial agent according to the present embodiment, a water-soluble polysaccharide having an average molecular weight of 1.8 million or more, diammine silver ion, and an organic acid or sugar having a reducing ability of the diammine silver ion are water-based. A reaction step of reacting in a solvent to obtain a reaction solution containing a water-soluble polysaccharide having an average molecular weight of 1.8 million or more, to which precipitated silver particles having a diameter of 1 nm or more are adhered in a dispersed state, and a reaction solution contained in the reaction solution. Since it has a liquid antibacterial agent preparation step of removing ammonium salts, nitrates, and silver salts to purify it into a liquid antibacterial agent, it is compared with the conventional antibacterial agent obtained by mixing a silver solution and a radish fermented liquid. It is possible to provide a method for producing a liquid antibacterial agent which is highly stable and can be used for antibacterial objects which are various liquids.

最後に、上述した各実施の形態の説明は本発明の一例であり、本発明は上述の実施の形態に限定されることはない。このため、上述した各実施の形態以外であっても、本発明に係る技術的思想を逸脱しない範囲であれば、設計等に応じて種々の変更が可能であることは勿論である。 Finally, the description of each embodiment described above is an example of the present invention, and the present invention is not limited to the above-described embodiment. Therefore, it goes without saying that various changes can be made according to the design and the like as long as the technical idea of the present invention is not deviated from the above-described embodiments.

Claims (7)

直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなる抗菌物質。 An antibacterial substance composed of water-soluble polysaccharides having an average molecular weight of 1.2 million or more, to which precipitated silver particles having a diameter of 1 nm or more are adhered in a dispersed state. 前記水溶性多糖類はヒアルロン酸とキサンタンガムとの複合体であることを特徴とする請求項1に記載の抗菌物質。 The antibacterial substance according to claim 1, wherein the water-soluble polysaccharide is a complex of hyaluronic acid and xanthan gum. 請求項1又は請求項2に記載の抗菌物質を水系溶媒中に溶解させた状態で含有する液状抗菌剤。 A liquid antibacterial agent containing the antibacterial substance according to claim 1 or 2 in a state of being dissolved in an aqueous solvent. 前記銀の濃度が80ppm以上であることを特徴とする請求項3に記載の液状抗菌剤。 The liquid antibacterial agent according to claim 3, wherein the silver concentration is 80 ppm or more. 平均分子量120万以上の水溶性多糖類と、ジアンミン銀イオンと、前記ジアンミン銀イオンの還元能を有する有機酸又は糖とを水系溶媒中で反応させて、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類を含む反応液を得る反応工程と、
前記反応液中に含まれるアンモニウム塩や硝酸塩、銀塩を除去して精製し液状抗菌剤とする液状抗菌剤調製工程と、を有することを特徴とする液状抗菌剤の製造方法。
A water-soluble polysaccharide having an average molecular weight of 1.2 million or more, diammine silver ion, and an organic acid or sugar having a reducing ability of the diammine silver ion are reacted in an aqueous solvent to obtain silver precipitated particles having a diameter of 1 nm or more. A reaction step of obtaining a reaction solution containing a water-soluble polysaccharide having an average molecular weight of 1.2 million or more attached in a dispersed state, and
A method for producing a liquid antibacterial agent, which comprises a step of preparing a liquid antibacterial agent by removing ammonium salts, nitrates and silver salts contained in the reaction solution and purifying the liquid antibacterial agent.
前記反応工程はアルカリ条件下で行うことを特徴とする請求項5に記載の液状抗菌剤の製造方法。 The method for producing a liquid antibacterial agent according to claim 5, wherein the reaction step is carried out under alkaline conditions. 対象物に対し、直径が1nm以上の銀の析出粒子を分散状態で付着させた平均分子量120万以上の水溶性多糖類よりなる抗菌物質を添加する微生物繁殖抑制方法。 A method for suppressing microbial growth by adding an antibacterial substance consisting of a water-soluble polysaccharide having an average molecular weight of 1.2 million or more, in which precipitated silver particles having a diameter of 1 nm or more are attached to an object in a dispersed state.
JP2021016902A 2015-05-18 2021-02-04 How to use antimicrobial substances Active JP7118465B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015101390 2015-05-18
JP2015101390 2015-05-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016098968A Division JP7199794B2 (en) 2015-05-18 2016-05-17 Liquid antibacterial agent and method for producing liquid antibacterial agent

Publications (3)

Publication Number Publication Date
JP2021066750A true JP2021066750A (en) 2021-04-30
JP2021066750A5 JP2021066750A5 (en) 2021-10-21
JP7118465B2 JP7118465B2 (en) 2022-08-16

Family

ID=57320250

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016098968A Active JP7199794B2 (en) 2015-05-18 2016-05-17 Liquid antibacterial agent and method for producing liquid antibacterial agent
JP2021016902A Active JP7118465B2 (en) 2015-05-18 2021-02-04 How to use antimicrobial substances

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016098968A Active JP7199794B2 (en) 2015-05-18 2016-05-17 Liquid antibacterial agent and method for producing liquid antibacterial agent

Country Status (4)

Country Link
JP (2) JP7199794B2 (en)
KR (1) KR102588589B1 (en)
CN (1) CN107529760B (en)
WO (1) WO2016185935A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102588589B1 (en) * 2015-05-18 2023-10-16 히데미 카키하라 Antibacterial substances and liquid antibacterial agents and methods for producing liquid antibacterial agents

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008120717A (en) * 2006-11-10 2008-05-29 Nippon Ion Kk Cosmetic composition
US20100317617A1 (en) * 2009-06-15 2010-12-16 Vascular Vision Pharmaceutical Co. Silver nanoparticles as anti-microbial
JP2011528694A (en) * 2008-07-23 2011-11-24 ユニヴァーシタ デグリ ステュディ デイ トリエステ Nanocomposites based on metal nanoparticles stabilized by branched polysaccharides
CN104548188A (en) * 2015-01-27 2015-04-29 王福亮 Hyaluronic acid-nano silver-based dressing and preparation method thereof
JP2016216454A (en) * 2015-05-18 2016-12-22 秀己 柿原 Antibacterial substance, liquid antibacterial agent, and method for producing the liquid antibacterial agent

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784991A (en) * 1986-03-14 1988-11-15 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
JPH04323309A (en) * 1991-04-12 1992-11-12 Daido Steel Co Ltd Production of fine metal powder
JP3882419B2 (en) * 1999-09-20 2007-02-14 旭硝子株式会社 Coating liquid for forming conductive film and use thereof
GB0025414D0 (en) * 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
PT1358883E (en) * 2002-04-30 2007-10-01 Sifi Spa Re-epithelializing pharmaceutical compositions containing xanthan gum
JP4342792B2 (en) * 2002-11-11 2009-10-14 株式会社大和化成研究所 Silver colloid antibacterial, bactericidal or antifungal composition and products using the composition
EP1654013B1 (en) * 2003-04-09 2009-11-11 Beiersdorf AG Antimicrobial materials
CA2585644A1 (en) * 2004-10-29 2006-05-11 Nanodynamics, Inc. Aqueous-based method for producing ultra-fine metal powders
JP2007291513A (en) * 2006-03-30 2007-11-08 Mitsui Mining & Smelting Co Ltd Silver particle
CA2711790A1 (en) * 2008-01-09 2009-10-29 Dan V. Goia Method for preparing dispersions of precious metal nanoparticles and for isolating such nanoparticles from said dispersions
CN101965201B (en) * 2008-01-30 2013-10-23 堪萨斯大学 Intralymphatic chemotherapy drug carriers
JP5139860B2 (en) * 2008-03-31 2013-02-06 三菱製紙株式会社 Method for producing silver ultrafine particles
IT1391669B1 (en) * 2008-07-23 2012-01-17 Universita' Degli Studi Di Trieste NANOCOMPOSITE MATERIALS FORMED FROM A POLYSACCHARIDIC MATRIX AND METALLIC NANOPARTICLES, THEIR PREPARATION AND USE
JP5296463B2 (en) 2008-09-05 2013-09-25 株式会社シフト Antibacterial agent
JP5892583B2 (en) * 2010-09-03 2016-03-23 株式会社タイキ Antibacterial silver ion production liquid, silver ion antibacterial liquid produced from the liquid, and production method for producing the antibacterial liquid
CN102000832A (en) * 2010-12-01 2011-04-06 中国人民解放军济南军区第四零一医院 Preparation method and purification process of nano silver
JP2014005241A (en) * 2012-06-26 2014-01-16 Yachiyo Industry Co Ltd Antimicrobial material
JP6248511B2 (en) * 2013-09-30 2017-12-20 凸版印刷株式会社 Thickening and coloring antibacterial agent, method for producing the same, and composition for personal care products
CN104525966B (en) * 2015-01-14 2016-10-26 河南大学 A kind of xanthan gum-argentum nano composite material and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008120717A (en) * 2006-11-10 2008-05-29 Nippon Ion Kk Cosmetic composition
JP2011528694A (en) * 2008-07-23 2011-11-24 ユニヴァーシタ デグリ ステュディ デイ トリエステ Nanocomposites based on metal nanoparticles stabilized by branched polysaccharides
US20100317617A1 (en) * 2009-06-15 2010-12-16 Vascular Vision Pharmaceutical Co. Silver nanoparticles as anti-microbial
CN104548188A (en) * 2015-01-27 2015-04-29 王福亮 Hyaluronic acid-nano silver-based dressing and preparation method thereof
JP2016216454A (en) * 2015-05-18 2016-12-22 秀己 柿原 Antibacterial substance, liquid antibacterial agent, and method for producing the liquid antibacterial agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XU, W ET AL.: "Green synthesis of xanthan conformation-based silver nanoparticles: Antibacterial and catalytic appl", CARBOHYDRATE POLYMERS, vol. 101, JPN6020011877, 2014, pages 961 - 967, ISSN: 0004702491 *

Also Published As

Publication number Publication date
JP7118465B2 (en) 2022-08-16
WO2016185935A1 (en) 2016-11-24
JP2016216454A (en) 2016-12-22
CN107529760A (en) 2018-01-02
KR20180008432A (en) 2018-01-24
JP7199794B2 (en) 2023-01-06
KR102588589B1 (en) 2023-10-16
CN107529760B (en) 2021-05-07

Similar Documents

Publication Publication Date Title
EP1175149B1 (en) Disinfecting composition based on h2o2, acids and metal ions
CN102559421B (en) Enzyme-containing fabric detergent with synergistic anticorrosion effect
JP2017537151A (en) Chelated metal oxide gel composition
CN102088860B (en) Concentrate for preparing disinfectant and preparation and use method thereof
JP7118465B2 (en) How to use antimicrobial substances
CN112755050B (en) Alcohol-free iodine-containing disinfectant with high component stability and preparation method thereof
CN106719667A (en) A kind of preparation method of shitosan synergistic antimicrobial liquid
CN111225564A (en) Antibacterial composition
WO2012153741A1 (en) IODINE-β-CYCLODEXTRIN INCLUSION COMPOUND SOLUTION
WO2018206867A1 (en) Novel bactericides and antifungal agents
JP2010057429A (en) Method for sterilizing food
CN114984194A (en) Composite lysozyme disinfectant
CN113749146A (en) Formula, preparation, application and using method of biofilm inhibitor
CN103875666A (en) Degerming composition and application thereof
JP4324346B2 (en) Organic acid formulation
JP4127529B2 (en) Organic acid formulation
JP4552165B2 (en) Industrial antibacterial agent composition and industrial antibacterial method
CN104082293B (en) A kind of composite alcohol sterilizing agent and its preparation method
US20140314738A1 (en) Disinfecting composition
CN109251798A (en) A kind of production method of dark green tea cleaning solution
CN102634074B (en) Chitin pulp and production method thereof
KR0164923B1 (en) Anti-bacterial agent containing chitosan
JP3702141B2 (en) Rust preventive and method for producing the same
TWI331900B (en) Composition comprising water-soluble chitin for use as microbicide, deodorizaing agent and/or pesticide, and method of controlling microorganisms in agriculture
JPH0235065A (en) Growth and propagation inhibitor for yeast or bacteria

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210308

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210308

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210617

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220609

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220628

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220727

R150 Certificate of patent or registration of utility model

Ref document number: 7118465

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150